Malaysia’s Xeraya Capital invests in GreenLight Biosciences’ $102m Series D round

Malaysia’s Xeraya Capital invests in GreenLight Biosciences’ $102m Series D round

Xeraya Capital CEO Fares Zahir

Malaysia’s lifesciences-focused private equity firm Xeraya Capital has invested an undisclosed sum in the Series D round of US-based GreenLight Biosciences.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter